In addition, PMN recruitment has been shown to aggravate experimental colitis [131]; this may occur via the PMN's ability to induce protective responses within IECs via the induction of hypoxia-inducible factor (HIF) [132] or the secretion of interleukin-22 (IL-22) [133]. The gene discussed is IL22; the disease is colitis.